Exscientia

About:

Exscientia is a pharmatech company that uses an end-to-end AI platform to design and discover new drugs.

Website: https://www.exscientia.ai

Twitter/X: exscientialtd

Top Investors: BlackRock, Evotec, Bristol-Myers Squibb, Marshall Wace, Novo Holdings

Description:

Exscientia combines human expertise with AI and machine learning to enhance drug discovery. The company focuses on precision engineering of medicine candidates, enabling faster and more efficient development of new treatments. By integrating innovative experimental techniques, Exscientia aims to improve patient outcomes and revolutionize the pharmaceutical industry.

Total Funding Amount:

$377M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Oxford, Oxfordshire, United Kingdom

Founded Date:

2012-01-01

Contact Email:

contact(AT)exscientia.co.uk

Founders:

Andrew Hopkins

Number of Employees:

251-500

Last Funding Date:

2023-12-05

IPO Status:

Public

© 2025 bioDAO.ai